Articles from Biotech Financial Reports (May 1, 1999)

Title	Author	Type	Words
ANTEX BIOLOGICS REPORTS NET LOSS FOR 1998.			419
BIOPOOL INTERNATIONAL'S 1998 SALES DROP 9 PERCENT FROM 1997.			760
CALYPTE BIOMEDICAL GETS $7 MILLION FROM SALE OF SHARES.			154
CARDIODYNAMICS REPORTS FIRST QTR RECORD $1.075 MILLION SALES.			698
CLINICOR REPORTS NET LOSS NARROWED BY 34 PERCENT IN 4TH QTR.			716
NEOPHARM REPORTS NET LOSS OF $1.6 MILLION FOR YEAR ENDED 1998.			311